Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk erk'

Search results for: 'research area mapk erk'

Items 21-30 of 36

Page
per page
  1. VX-11e
    A3931 VX-11e
     5 Citation
    Target: ERK
    Summary: ERK inhibitor
      ≥25 mg/mL
  2. PD98059
    A1663 PD98059
     9 Citation
    Target: MEK
    Summary: MEK inhibitor,selective and reversible
      insoluble in EtOH; insoluble in H2O; ≥40.23 mg/mL
  3. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
  4. SB 203580 hydrochloride
    B1285 SB 203580 hydrochloride
    Target: p38
    Summary: Specific p38-MAPKs inhibitor
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  5. VRT752271
    B1106 VRT752271
    Target: ERK
    Summary: ERK1/ERK2 inhibitor
      ≥43.3 mg/mL
  6. Gemcitabine
    A8437 Gemcitabine
     1 Citation
    Summary: inhibitor of DNA synthesis
      ≥11.75 mg/mL
  7. Gabapentin
    A8436 Gabapentin
    Summary: GABA enhancer
  8. PF-3644022
    B5549 PF-3644022
    Target: MK2
    Summary: Potent and Selective MK2 inhibitor
      <14.98 mg/mL
  9. AZD8330
    A8374 AZD8330
    Target: MEK
    Summary: MEK 1/2 inhibitor
      ≥23.05 mg/mL
  10. Clemizole hydrochloride
    A3316 Clemizole hydrochloride
    Target: Histamine H1 Receptors|TRPC channel
    Summary: H1 histamine receptor antagonist

Items 21-30 of 36

Page
per page